Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2017

Open Access 01-12-2017 | Research article

A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients

Authors: Andrea Manfrin, Michela Tinelli, Trudy Thomas, Janet Krska

Published in: BMC Health Services Research | Issue 1/2017

Login to get access

Abstract

Background

The economic burden of asthma, which relates to the degree of control, is €5 billion annually in Italy. Pharmacists could help improve asthma control, reducing this burden. This study aimed to evaluate the effectiveness and cost-effectiveness of Medicines Use Reviews provided by community pharmacists in asthma.

Methods

This cluster randomised, multi-centre, controlled trial in adult patients with asthma was conducted in 15 of the 20 regions of Italy between September 2014 and July 2015. After stratification by region, community pharmacists were randomly allocated to group A (trained in and delivered the intervention at baseline) or B (training and delivery 3 months later), using computerised random number generation in blocks of 10. Each recruited up to five patients, with both groups followed for 9 months.
The intervention consisted of a systematic, structured face-to-face consultation with a pharmacist, covering asthma symptoms, medicines used, attitude towards medicines and adherence, recording pharmacist-identified pharmaceutical care issues (PCIs). The primary outcome was asthma control, assessed using the Asthma-Control-Test (ACT) score (ACT ≥ 20 represents good control). Secondary outcomes were: number of active ingredients, adherence, cost-effectiveness compared with usual care. Although blinding was not possible for either pharmacists or patients, assessment of outcomes was conducted by researchers blind to group allocation.

Results

Numbers of pharmacists and patients enrolled were 283 (A = 136; B = 147) and 1263 (A = 600; B = 663), numbers completing were 201 (A = 97; B = 104) and 816 (A = 400; B = 416), respectively. Patients were similar in age and gender and 56.13% (458/816) had poor/partial asthma control. Pharmacists identified 1256 PCIs (mean 1.54/patient), mostly need for education, monitoring and potentially ineffective therapy. Median ACT score at baseline differed between groups (A = 19, B = 18; p < 0.01). Odds ratio for improved asthma control was 1.76 (95% CI 1.33–2.33) and number needed to treat 10 (95% CI 6–28). Number of active ingredients reduced by 7.9% post-intervention (p < 0.01). Adherence improved by 35.4% 3 months post-intervention and 40.0% at 6 months (p < 0.01). The probability of the intervention being more cost-effective than usual care was 100% at 9 months.

Conclusions

This community pharmacist-based intervention demonstrated both effectiveness and cost-effectiveness. It has since been implemented as the first community pharmacy cognitive service in Italy.

Trial registration

TRN: ISRCTN72438848 (registered 5th January 2015, retrospectively).
Literature
1.
De Marco R, Cappa V, Accordini S, Rava M, Antonicelli L, Bortolami O, et al. Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J. 2012;39:883–92.CrossRefPubMed
2.
3.
4.
Gupta R, Sheikh A, Strachan DP, Handerson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy. 2004;34:520–6.CrossRefPubMed
5.
Anandan C, Gupta R, Simpson CR, Fishbacher C, Sheikh A. Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases. J R Soc Med. 2009;102:431–42.CrossRefPubMedPubMedCentral
6.
Accordini S, Corsico AG, Braggion M, Gerbase MW, Gislason D, Gulsvik A, et al. The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol. 2013;160:93–101.CrossRefPubMed
7.
Accordini SM, Bugiani Arossa W, Gerzeli S, Marinoni A, Olivieri M, et al. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol. 2006;141:189–98.CrossRefPubMed
8.
9.
10.
Scottish Intercollegiate Guidelines Network (SIGN 141). British guideline on management of asthma. A national clinical guideline. Healthcare Improvement Scotland. www.sign.ac.uk/pdf/SIGN141.pd (2014). Accessed 8 Jan 2016.
11.
12.
13.
Vervloet D, Williams AE, Lloyd A, Clark TJH. Costs of managing asthma as defined by a derived asthma control test score in seven European countries. Eur Respir Rev. 2006;15(98):17–23.CrossRef
14.
Braido F, Baiardini I, Balestracci S, Fassio O, Ravera S, Belotti M, et al. The relationship between asthma control and quality-of-life impairment due to chronic cough: a real-life study. Ann Allergy Asthma Immunol. 2008;101(4):370–4.CrossRefPubMed
15.
Demoly P, Annunziata K, Gubba E, Adamek L. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years. Eur Respir Rev. 2012;21(123):66–74.CrossRefPubMed
16.
Allemann S, van Mill JW, Boterman L, Berger K, Griese N, Hersberger KE. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharmacol. 2014;36(3):544–55.CrossRef
17.
Barbanel D, Eldridge S, Griffiths C. Can a self-management programme delivered by a community pharmacist improve asthma control? A randomised trial. Thorax. 2003;58(10):851–4.CrossRefPubMedPubMedCentral
18.
Bunting BA, Cranor CW. The Asheville project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46(2):133–47.CrossRef
19.
Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2001;21(10):1196–203.CrossRefPubMed
20.
Emmerton L, Shaw J, Kheir N. Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project. J Clin Pharm Ther. 2003;28(5):395–402.CrossRefPubMed
21.
Mangiapane S, Schulz M, Mühlig S, IHle P, Schubert I, Waldman HC. Community pharmacy-based pharmaceutical care for asthma patients. Ann Pharmacother. 2005;39(11):1817–22.CrossRefPubMed
22.
McLean W, Gillis J, Waller R. The BC community pharmacy asthma study: a study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J. 2003;10:195–202.CrossRefPubMed
23.
Narhi U, Airaksinen M, Tanskanen P, Erlund H. Therapeutic outcomes monitoring by community pharmacists for improving clinical outcomes in asthma. J Clin Pharm Ther. 2000;25:177–83.CrossRefPubMed
24.
Saini B, Krass I, Armour C. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother. 2004;38:1954–60.CrossRefPubMed
25.
Schulz M, Verheyen F, Mühlig S, Müller JM, Mühlbauer K, Knop-Schneickert E, et al. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol. 2001;41:668–76.CrossRefPubMed
26.
Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, et al. Pharmacy asthma care program (PACP) improves outcomes for patients in the community. Thorax. 2007;62:496–502.CrossRefPubMedPubMedCentral
27.
Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, et al. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J. 2008;31(4):790–9.CrossRefPubMed
28.
García-Cárdenas V, Sabater-Hernández D, Kenny P, Martinez-Martinez F, Faus MJ, Benrimoj SI. Effect of a pharmacist intervention on asthma control. A cluster randomised trial. Respir Med. 2013;107(9):1346–55.CrossRefPubMed
29.
Garcia-Cardenas V, Armour C, Benromoj SI, Martinez-Martinez F, Rotta I, Fernandez-Llimos F. Pharmacists’ interventions on clinical asthma oucomes: a systematic review. Eur Respir J. 2016;47:1043–6.CrossRef
30.
31.
Houle SKD, Grindord AK, Chatterly T, Tsuyuki RT. Paying pharmacists for patient care. A systematic review of remunerated pharmacy clinical services. Can Pharm J. 2014;147(4):209–32.CrossRef
32.
Gums T, Carter B, Foster E. Cluster randomised controlled trials for pharmacy practice research. Int J Clin Pham. 2016;38(3):607–14.
33.
Manfrin A, Thomas T, Krska J. Randomised evaluation of the Italian medicines use review provided by community pharmacists using asthma as a model (RE I-MUR). BMC Health Serv Res. 2015;15:171. http://​dx.​doi.​org/​10.​1186/​s12913-015-0791-6. Accessed 15 Dec 2015.CrossRefPubMedPubMedCentral
34.
Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D. Providing pharmaceutical care using a systematic approach. Pharm J. 2000;265:656–60.
35.
Bettoncelli G, Magnoni MG, Fassari C, Tosatto R, Di Blasi P, De Marco R et al. (POINT OUT ASTHMA CONTROL ITALIAN SURVEY) Il controllo dell’asma in Italia misurato con Act A(Asthma Control Test) STUDIO P.A.C.I.S. (Point out Asthma Control Italian Survey) Il controllo dell’asma in Italia misurato con ACT (Asthma Control Test). https://​www.​simg.​it/​documenti/​rivista/​2006/​06_​2006/​3.​pdf. Accessed 10 March 2014.
36.
Thomas M, Kay S, Williams A, Pike J, Williams A, Carranza JR, et al. The asthma control test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Respir J. 2009;18:41–9.CrossRefPubMed
37.
Morisky DE, Alfonso A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in outpatient setting. J Clin Hypertens. 2008;10(5):348–54.CrossRef
38.
Killip S, Mahfoud Z, Pearce K. What is an intracluster correlation coefficent? crucial concepts for primary care researchers. Ann Fam Med. 2004;2(3):204–8.CrossRefPubMedPubMedCentral
39.
40.
McCrum-Gardner E. Which is the correct statistical test to use? Br J Oral Maxillofac Surg. 2008;46(1):38–41.CrossRefPubMed
41.
Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statements: extension to cluster randomised trials. Research methods and reporting. BMJ. 2012;345:e5661.CrossRefPubMed
42.
Galbraith S, Daniel JA, Vissel B. A study of cluster data and approaches to its analysis. J Neurosci. 2010;30(32):10601–8.CrossRefPubMed
43.
44.
45.
46.
Meid AD, Lampert A, Burnett A, Seidling HM, Haefeli WE. The impact of pharmaceutical care interventions for medication underuse in older people: a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;80:768–76.CrossRefPubMedPubMedCentral
47.
Wu JYF, Leung WYS, Chang S, Lee B, Zee B, Tong P, Chan J. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ. 2006;333:522.CrossRefPubMedPubMedCentral
48.
Armour CL, Reddel HK, LeMay KS, Saini B, Smith LD, Bosnic-Anticevich SZ, et al. Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial. J Asthma. 2013;50(3):302–9.CrossRefPubMed
49.
50.
51.
Bagole LE, Beaumont A, Morgan I. Outcomes of medicines use reviews for people with asthma. Int J Pharm Pract. 2007;15 Suppl 2:B6.
52.
Hatah E, Braund R, Tordoff J, Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol. 2014;77(1):102–15.CrossRefPubMed
53.
Metadata
Title
A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients
Authors
Andrea Manfrin
Michela Tinelli
Trudy Thomas
Janet Krska
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2017
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-017-2245-9

Other articles of this Issue 1/2017

BMC Health Services Research 1/2017 Go to the issue

Research article

Implementation fidelity of a nurse-led falls prevention program in acute hospitals during the 6-PACK trial

Research article

Patient experiences of engagement with care plans and healthcare professionals’ perceptions of that engagement

Research article

Comparing chronic condition rates using ICD-9 and ICD-10 in VA patients FY2014–2016

Research article

Development and validation of a structured observation scale to measure responsiveness of physicians in rural Bangladesh

Research article

Do healthier lifestyles lead to less utilization of healthcare resources?

Research article

Outcomes for primary kidney transplantation from donation after Citizens’ death in China: a single center experience of 367 cases